# Eurospital S.P.A.

- Location (FDA's records): Trieste, IT
- FDA decisions: 5 (2000–2019): 5 510(k) clearances
- Names in FDA's records: Eurospital S.P.A. (4); Eurospital (1)
- Product codes: NXO (4), LHI (1)
- Predicates its devices cite: 4 (3 its own); citations of its devices by later devices: 6 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Genova Diagnostics: 1 (https://510kreport.com/company/genova-diagnostics)

## Firms that cite its devices most
- Inova Diagnostics, Inc.: 1 (https://510kreport.com/company/inova-diagnostics)
- ALPCO: 1 (https://510kreport.com/company/alpco)
- Buhlmann Laboratories AG: 1 (https://510kreport.com/company/buhlmann-laboratories)

## Its most-cited devices
- K160447: Calprest NG (2016), cited by 4
- K130945: Calprest (2014), cited by 2

## Recent decisions
- K191589: Calprest, EasyCal (Jul 10, 2019)
- K191592: CalprestNG, EasyCal (Jul 10, 2019)
- K160447: Calprest NG (Nov 10, 2016)
- K130945: Calprest (Jan 16, 2014)
- K000367: Securmix (Feb 29, 2000)

Source page: https://510kreport.com/company/eurospital